"Patients choose Medical Oncology and Hematology at Mercy because of our expert team of doctors and their collaborative approach to developing comprehensive treatment plans. Our medical oncologists focus on treating cancers and blood disorders with chemicals, biological products and immunotherapy to stop or slow the growth of cancers, treat disease and diminish symptoms. Our cancer doctors work in concert with nationally certified oncology nurses, radiation oncologists, surgeons, counselors, dietitians and genetic experts to provide complete and focused care for patients."

During the past decade, Mercy Medical Center Medical Oncology & Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Medical Center Medical Oncology & Hematology" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Medical Center Medical Oncology & Hematology" are "Breast Cancer" (4 trials), "Metastatic Breast Cancer" (1 trials) and "Neuroendocrine Tumors" (1 trials). Many other conditions were trialed in "Mercy Medical Center Medical Oncology & Hematology" in a lesser frequency.

Most popular intervention types in "Mercy Medical Center Medical Oncology & Hematology" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "trastuzumab emtansine" (2 trials), "Capecitabine" (1 trials), "Eribulin" (1 trials), "Everolimus" (1 trials) and "Everolimus Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Medical Center Medical Oncology & Hematology" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Medical Center Medical Oncology & Hematology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mercy Medical Center Medical Oncology & Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Medical Center Medical Oncology & Hematology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".